UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012031
Receipt number R000014059
Scientific Title Placebo-controlled, double-blind, crossover clinical trial for the effect of single intake of soybean processed food rich in beta-conglycinin on postprandial hyperlipidemia
Date of disclosure of the study information 2013/10/15
Last modified on 2013/12/01 18:05:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Placebo-controlled, double-blind, crossover clinical trial for the effect of single intake of soybean processed food rich in beta-conglycinin on postprandial hyperlipidemia

Acronym

Effect of beta-conglycinin-rich soybean on postprandial hyperlipidemia

Scientific Title

Placebo-controlled, double-blind, crossover clinical trial for the effect of single intake of soybean processed food rich in beta-conglycinin on postprandial hyperlipidemia

Scientific Title:Acronym

Effect of beta-conglycinin-rich soybean on postprandial hyperlipidemia

Region

Japan


Condition

Condition

dyslipidemia

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose is to evaluate the effects of high beta-conglycinin-contained soy bean for postprandial serum triglyceride by double-blind, placebo-controlled cross over test.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

TG

Key secondary outcomes

T-CHO, HDL-CHO, LDL-CHO, plasma glucose, insulin, NEFA, RLP-CHO, phospholipid, ApoB, VAS


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake beta-conglycinin-rich soybean processed food, and then ingest beta-conglycinin-poor soybean processed food after 1 week washout period.

Interventions/Control_2

Intake beta-conglycinin-poor soybean processed food, and then ingest beta-conglycinin-rich soybean processed food after 1 week washout period.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

1)Subjects who show high serum content of triglyceride after meal.
2)Subjects who agree to participate in the current study with written informed consent.

Key exclusion criteria

1)Subjects who are under medication for chronic ailments.
2)Subjects with serious diseases and infections.
3)Subjects with clinical history of gastrointestinal surgery.
4)Subjects with frequent complaints of post-menopausal symptoms.
5)Subjects with unusually high and/or low blood pressure, or with abnormal hematological data.
6)Subjects with serious anemia.
7)Subjects with a history of allergy to medicine and food, especially soybean.
8)Subjects routinely on supplementation which would affect the lipid metabolism.
9)Heavy smokers and alcohol addicts, or subjects with irregular lifestyle.
10)Subjects who donate 400ml whole blood within 12 weeks or who donate plasma or platelets within 4 weeks prior to supplementation.
11)Subjects who are pregnant or under lactation, or ones who would be expected to be pregnant during the study.
12)Subjects who participate in other clinical trials within the last one month prior to the current clinical trial.
13)Subjects who are not eligible due to physician's judgment

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Prof. Jun Nishihira, M.D.

Organization

Hokkaido Information University

Division name

Department of Medical Management and Informatics

Zip code


Address

59-2, nishi-nopporo, ebetsu, 069-8585, Hokkaido

TEL

011-385-4411

Email

nishihira@do-johodai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Dir. Prof. Jun Nishihira, M.D.

Organization

Hokkaido Information University

Division name

Health Information Science Center

Zip code


Address

59-2, nishi-nopporo, ebetsu, 069-8585, Hokkaido

TEL

011-385-4430

Homepage URL

http://biosv2.do-johodai.ac.jp/

Email

nishihira@do-johodai.ac.jp


Sponsor or person

Institute

Hokkaido Information University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Agriculture, Forestry and Fisheries

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kinki university faculty of agriculture,
National Agriculture and Food
Research Organization,
Nagano Research Center of Vegetable and Floricultural Science,
Asahimatsu Foods co., Ltd.,
Minami sangyo co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道情報大学 保健センター(北海道)


Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 10 Month 11 Day

Date of IRB


Anticipated trial start date

2013 Year 10 Month 30 Day

Last follow-up date

2013 Year 11 Month 21 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 10 Month 14 Day

Last modified on

2013 Year 12 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014059


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name